title: A paradigm shift in anti-platelet therapy?
authors.affiliation: Département de cardiologie, Hôpital universitaire nord de Marseille, Faculté de medecine de Marseille, Marseille, France. laurentbonello@yahoo.fr
authors.forename: L
authors.initials: L
authors.lastname: Bonello
authors.forename: P
authors.initials: P
authors.lastname: Barragan
authors.forename: F
authors.initials: F
authors.lastname: Paganelli
mesh_terms: D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine